Journal article
Intravenous (IV) azithromycin (AZM)/ceftriaxone followed by PO AZM versus IV lefofloxacin (LEV) followed by PO LEV in treatment of hospitalized patients with community-acquired pneumonia
Abstract
Aim. Treatment options for hospitalized community-acquired pneumonia (CAP) patients include a β-lactam/macrolide combination or monotherapy with an antipneumococcal fluoroquinolone. We compared clinical efficacy/safety of sequential therapy with intravenous (IV) azithromycin (AZM; 500 mg qd)/ceftriazone (CEF; 1 g qd) followed by PO AZM (500 mg qd) versus IV levofloxacin (LEV 500 mg qd) followed by PO LEV (500 mg qd) in patients with …
Authors
Zervos M; Andrews C; Amsden G; Knirsch C; Swanson R; De Caprariis P; Mandell L
Journal
Minerva Pneumologica, Vol. 43, No. 4, pp. 183–188
Publication Date
December 1, 2004
ISSN
0026-4954